Is gamma-glutamyl transferase a marker of oxidative stress and cardiometabolic risk?

Gamma-glutamyl transferase (GGT) has evolved beyond its traditional role as a simple indicator of liver or biliary tract health. Current research identifies it as a highly sensitive biomarker of systemic oxidative stress and a prognostic indicator for metabolic and cardiovascular outcomes, even when levels are comfortably within the standard clinical reference range.

GGT as a Biomarker of Oxidative Stress

GGT plays a critical role in cellular defense by managing glutathione (GSH), the body's primary antioxidant. Its utility as a biomarker stems from two distinct mechanistic pathways:

• Adaptive Upregulation: When systemic oxidative stress increases, GGT expression is adaptively upregulated to break down extracellular glutathione into its constituent amino acids. This recycling process is essential for maintaining intracellular GSH levels to combat redox imbalances.
• Pro-oxidant Activity: Paradoxically, GGT activity itself can generate oxidative stress. During the breakdown of glutathione, GGT produces cysteinyl-glycine, which reacts with transition metals like iron. This triggers Fenton-like reactions, generating reactive hydroxyl radicals and increasing lipid peroxidation. Because of this dual role, serum GGT levels are positively correlated with markers of oxidative damage like malondialdehyde (MDA).

Cardiovascular and Metabolic Risk

Longitudinal data indicate that GGT levels in the "high-normal" range are significant predictors of long-term health risks:

• Cardiovascular Mortality: Large-scale studies involving over 76,000 adults have shown that even within normal ranges, increases in GGT are associated with a 40% higher hazard ratio (HR 1.40) for total cardiovascular disease mortality in men.
• Sudden Cardiac Death (SCD): In middle-aged cohorts, every 1 standard deviation increase in baseline GGT correlates with a higher risk of SCD. The highest quartiles of GGT (still within reference limits) show up to a 51.9% increased risk compared to the lowest quartiles.
• Metabolic Syndrome: GGT acts as an independent marker of metabolic dysfunction. Its levels rise linearly as individuals accumulate metabolic syndrome criteria, reflecting the underlying burden of oxidative stress and chronic inflammation.

Bottom line

GGT is a robust marker of oxidative stress and glutathione metabolism. For middle-aged individuals, levels at the higher end of the reference range are not benign; they are clinically significant indicators of increased risk for ischemic heart disease, sudden cardiac death, and metabolic syndrome.